Top Drug Accelerators & VCs (2026)

Upfront Ventures is the venture capital firm focusing on early-stage technology companies.

B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.

SOSV is a multi-stage VC firm with $1.3B AUM focused on human and planetary health and operating HAX, IndieBio, Orbit Startups and dlab.

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B i…

Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.

Discover. Launch. Build. Transform.

CRCM Ventures invests in early stage companies, targeting consumer, climate tech, frontier tech, health, and fintech industries.

RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

We are Abingworth a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

We back visionary founders who are building technologies of the future.

Healthcare-only platform spanning seed through IPO and beyond via public, private and credit/royalty arms; acts as a biotech IPO accelerator and validation, aid…

Solu Therapeutics Closes $41M Series A…

Exclusive synthetic biology investor focused on companies replacing industrial inputs with biology-based alternatives, led by a UCSF-trained PhD cell biologist…

UC Berkeley’s premier startup accelerator and incubator program

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.

Founded in 2013, Celesta Capital is a global deep tech venture firm backing the breakthroughs that will power the next decade of technology advancement. Led by…

NOON Ventures | Early-Stage Deeptech Venture Capital Fund

Enabling Awesome

Lightstone Ventures – Investing in Medical Breakthroughs We don’t just invest in ideas. We invest in people.

We invest in emerging markets and turn ideas into legendary companies

CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.

Draper B1 is a seed and early-stage venture capital firm that invests in B2B and B2B2C startups.

About NGN Capital

Helping Extraordinary Entrepreneurs Build Exceptional Companies

WE BACK ENTREPRENEURS CREATING VALUE WITH DIGITAL HEALTH SOLUTIONS

Early-stage accelerator for synthetic biology and life sciences that gives scientist-founders lab independence with co-located BSL-rated wet labs and extended r…

Invests in companies addressing fundamental societal needs, systematizes mission-based narratives, and offers a Talent/Capital/Attention platform to recruit tal…

Fueling theFuture ofWellbeing

Next Level Ventures.

Select Investments

Life Extension Ventures

Noetic Fund invests in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies.

PsyMed Ventures - Frontier Brain and Mental Health Venture Capital Fund

We believe in the primacy of great markets and great people all aligned with one mission

Asabys Partners is based in Barcelona and specialises in early-stage biotech, medical technology and healthcare innovation projects.

Pureos Bioventures is a new venture capital fund

weVENTURE | weVENTURE | Florida Tech

Rittenhouse Ventures | Philadelphia-Based Early-Stage Venture Fund Powering Innovation Since 2008

Investing with conviction in visionary technical founders inventing the future.

AV8 Ventures | Empowering the bold

Co-founder and General Partner, Realist Ventures

Realist Ventures

Kotti Capital is a venture capital firm.

a hands-on partner for innovative team technology with worldwide impact

Kineticos Ventures Invests in biotechs looking to disrupt how drugs are developed, diseases are diagnosed and patients are treated. We focus on the areas of gre…

Novartis Digital Health Venture Capital

Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.

Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.

We are a venture capital fund that works with entrepreneurs responding to the global challenges caused by an ageing society. We support projects that use techno…

We are an early-stage venture capital firm, founded by top accelerator alumni.

N/A

We are an investment fund supporting advancements in understanding and treating neurological conditions.

We are £100m UK-based technology fund that backs revenue positive businesses that are looking to generate significant positive impact for climate and natural ec…

Angel investor

We are a firm dedicated to capital ventures in the life sciences sector.

The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies…

We are a global investment firm that forms partnerships with various entities.

We are a leading Danish VC and fundraiser. We have since 2018 invested nearly € 200 million in various Tech and Life Science startups.

We are a specialized venture capital company.

We are a seed-stage fund dedicated to advancing innovative companies in the life sciences sector.

We are a bio-innovation center partner providing smart money investments.

N/A

We develop and manufacture pharmaceutical aerosol drug delivery devices.

We are a company specializing in providing capital for scientific and health innovations.

We are an investment company focused on these industries.

Harriet Ventures is a global private equity investment firm based in the United States. We focus on identifying exceptional companies and propelling them to new…

We are an investment firm specializing in the health sector.

We are an innovation fund.

N/A

We are an early-stage investor.